ASO Author Reflections: APRI + ALBI: A Novel Tool for Estimating Chemotherapy-Associated Liver Injury in Patients with Colorectal Cancer Liver Metastasis Undergoing Liver Resection
- PMID: 31037436
- PMCID: PMC6901421
- DOI: 10.1245/s10434-019-07395-8
ASO Author Reflections: APRI + ALBI: A Novel Tool for Estimating Chemotherapy-Associated Liver Injury in Patients with Colorectal Cancer Liver Metastasis Undergoing Liver Resection
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Comment on
-
The Combination of APRI and ALBI Facilitates Preoperative Risk Stratification for Patients Undergoing Liver Surgery After Neoadjuvant Chemotherapy.Ann Surg Oncol. 2019 Mar;26(3):791-799. doi: 10.1245/s10434-018-07125-6. Epub 2019 Jan 7. Ann Surg Oncol. 2019. PMID: 30617869 Free PMC article.
References
-
- Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371:1007–1016. doi: 10.1016/S0140-6736(08)60455-9. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
